01—Abstract
Summary
Summary of the 8-K filed October 2, 2025. Cited figures are marked; the original filing is the authoritative source.
On October 2, 2025, Occidental Petroleum (OXY) and Berkshire Hathaway announced a definitive agreement under which Berkshire will acquire Occidental Chemical Corporation (OxyChem), Occidental's chemical business, in an all-cash transaction valued at $9.7 billiona, subject to customary purchase price adjustments.
The filing is a Regulation FD disclosure furnishing the joint press release and an investor presentation; the information is not deemed "filed" under Section 18 of the Exchange Act. Occidental plans to use $6.5 billionb of the proceeds to repay debt, bringing principal debt below its $15 billion target set after the December 2023 CrownRock acquisition, and to put the remaining roughly $1.5 billion after tax toward the balance sheet. Management expects annual interest expense savings of more than $350 million.
The company also frames the sale as a way to sharpen focus on its oil and gas business, which management says will allow it to reallocate capital to high-return projects, pursue advanced recovery technologies, and begin a multi-year, opportunistic share repurchase program. An Occidental subsidiary will retain OxyChem's legacy environmental liabilities, and Glenn Springs Holdings will continue managing existing remedial projects. The transaction is expected to close in the fourth quarter of 2025, subject to regulatory approvals and other customary closing conditions.
Key risks include the possibility that regulatory approvals are delayed or not obtained, the transaction failing to deliver its expected benefits, and management distraction. The filing does not disclose the financial performance of OxyChem, so investors will need to assess the implied value and the strategic trade-off against the company's lost chemical earnings.
02—Key points
Key Highlights
- Berkshire Hathaway will acquire 100% of Occidental Chemical Corporation (OxyChem) for $9.7 billion in cash, subject to customary purchase price adjustments.
- About $6.5 billion of proceeds will be used to repay debt, achieving the post-CrownRock principal debt target of below $15 billion.
- Remaining roughly $1.5 billion of after-tax proceeds goes to the balance sheet, and management expects more than $350 million in annual interest expense savings.
- Management plans to reallocate capital to high-return oil and gas projects, accelerate low-cost resource development, and advance recovery technologies such as CO2 EOR and water floods.
- Occidental plans an opportunistic, multi-year share repurchase program and a sustainable, growing dividend, with preferred equity redemption expected to begin in August 2029.
- A subsidiary of Occidental will retain OxyChem's legacy environmental liabilities; Glenn Springs Holdings will continue managing existing remedial projects.
- Closing is expected in Q4 2025, subject to regulatory approvals and customary conditions; Barclays is financial advisor and Cravath, Swaine & Moore is legal counsel.
03—Questions
Frequently Asked Questions
How much is Berkshire Hathaway paying for OxyChem and how will the proceeds be used?
Berkshire is paying $9.7 billion in cash, subject to customary purchase price adjustments. Occidental expects to use about $6.5 billion to repay debt, with the remaining roughly $1.5 billion after tax going to the balance sheet.
When is the transaction expected to close and what could prevent it?
The transaction is expected to close in the fourth quarter of 2025. Closing is subject to regulatory approvals and other customary conditions, and the filing notes risks that these conditions may not be satisfied or waived on the expected timeline or at all.
Does the sale of OxyChem change Occidental's strategic focus?
Yes. Management says the sale allows Occidental to focus more on its oil and gas business, accelerate development in its U.S. onshore and Gulf of America assets, and reallocate capital toward high-return projects and advanced recovery technologies.
What does this mean for shareholder returns?
Reducing debt below the $15 billion target is intended to enhance shareholder returns. Management cites a sustainable, growing dividend and an opportunistic multi-year share repurchase program, and says preferred equity redemption is expected to begin in August 2029, likely preceded by balance sheet cash build-up.
Will Occidental retain any liabilities related to OxyChem?
Yes. A subsidiary of Occidental will retain OxyChem's legacy environmental liabilities, and Glenn Springs Holdings will continue to manage existing remedial projects for that subsidiary.
04—Continue